Provided by Tiger Trade Technology Pte. Ltd.

Sanofi SA

40.23
+0.03000.07%
Post-market: 40.370.1387+0.34%16:32 EDT
Volume:3.00M
Turnover:119.58M
Market Cap:96.39B
PE:21.58
High:40.27
Open:40.18
Low:39.58
Close:40.20
52wk High:52.68
52wk Low:39.18
Shares:2.40B
Float Shares:2.16B
Volume Ratio:0.75
T/O Rate:0.14%
Dividend:2.36
Dividend Rate:5.88%
EPS(TTM):1.86
EPS(LYR):3.76
ROE:5.71%
ROA:5.09%
PB:1.24
PE(LYR):10.70

Loading ...

Pharmaceutical Stocks Jump. Moderna, Eli Lilly up over 3%; Novavax, Pfizer up Around 2%; Merck, Novo Nordisk up over 1%

Tiger Newspress
·
Sep 24

European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading

MT Newswires Live
·
Sep 23

Sanofi’s Chinese Pediatric Meningococcal Vaccine Trial Advances, Sharpening Long-Term Growth Prospects for SNY

TIPRANKS
·
Sep 23

European Pharma Leaders Push for National Reforms to Boost Investment

Dow Jones
·
Sep 22

Sanofi Targets Teen Acne With New mRNA Vaccine Trial, Opening a Fresh Growth Avenue for SNY

TIPRANKS
·
Sep 19

Sector Update: Healthcare

MT Newswires Live
·
Sep 17

Sanofi Targets Senior Respiratory Risk With New Phase 2b RSV+HMPV Vaccine Trial

TIPRANKS
·
Sep 17

Sanofi Opens New Flu Vaccine Facility in Toronto

MT Newswires Live
·
Sep 17

Sanofi inaugurates Canadian flu vaccine faclity

TIPRANKS
·
Sep 16

Sanofi to Acquire 26.4% Stake in Cheplapharm

MT Newswires Live
·
Sep 14

Sanofi, Cheplapharm enter strategic partnership

TIPRANKS
·
Sep 14

Sanofi, Regeneron Could Extend Dupixent Patent

Dow Jones
·
Sep 09

Sanofi Will Need More Trials to Set New Asthma Drug Apart from Rival

Dow Jones
·
Sep 09

Regeneron Seen Weighing Expanded Sanofi Deal, RBC Says

MT Newswires Live
·
Sep 01

Arrowhead Pharmaceuticals' sHTG Therapy Could Get FDA Approval by Q2 2027, RBC Says

MT Newswires Live
·
Aug 31

Sanofi's Lunsekimig Needs to Deliver

Dow Jones
·
Aug 24

Sanofi’s New H5N8 Flu Vaccine Trial Signals Long-Term Pandemic Preparedness Play

TIPRANKS
·
Aug 22

European Equities Traded in the US as American Depositary Receipts Head Lower in Tuesday Trading

MT Newswires Live
·
Aug 18

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 11

Nurix Therapeutics' STAT6 Degrader Likely to Receive Increased Recognition, RBC Says

MT Newswires Live
·
Aug 11